DXR News and Press, Daxor Corporation From 07/08/20

NEW YORK, July 08, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measurement, has signed a new distribution agreement with American Medical Depot “AMD,...

NEW YORK, June 30, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measurement, today announced the appointments of Dr. Henry D. Cremisi and Joy Goudie, Esq. to the...

A Deeper Look Reveals New Concerns and Adds To Our Conviction Zynex (NASDAQ: ZYXI ) shares are up 150% year to date vs the Health Care Select SPDR ETF (NYSE: XLV) at -2%. We believe ZYXI's outperformance is a function of retail investor complacency combined with sell-side analyst careless...

NEW YORK, May 26, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measurement, today announced that its CEO, Michael Feldschuh, will be a panelist in Maxim Group an...

NEW YORK, May 22, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measurement, today announced that blood volume outcome data has been published in the scientific j...

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , Apple ...

Takeda Teams Up with ProThera on IAIP Therapy Takeda Pharmaceutical Company Limited ( TAK ) announced inking a new deal with ProThera Biologics for the purpose of developing IAIP therapy. This plasma-derived therapy is intended to be used for treating acute inflammatory conditions. Both th...

New York, April 23, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measurement, today announced that the United States Department of Defense (DOD) has awarded th...

Bellerophon Therapeutics (NASDAQ: BLPH ) +472% on FDA nod for emergency use of INOpulse for Covid-19. More news on: Bellerophon Therapeutics, Inc., Rand Capital, GenMark Diagnostics, Inc., Stocks on the move, Read more ...

Daxor (NYSEMKT: DXR ) announces the first use of its BVA-100 test to guide volume treatment in COVID-19 patients and released a clinical protocol for fluid guidance for the same. More news on: Daxor Corporation, Healthcare stocks news, Read more ...